Sirolimus for Vincristine ‐Resistant Kasabach–Merritt Phenomenon: Report of Eight Patients

ConclusionIn this small case series, we found sirolimus to be highly effective, with minimal side effects, for vincristine‐resistant KMP. A larger study to compare sirolimus and vincristine for KMP is warranted.

Source: Pediatric Dermatology - December 31, 2016 Category: Dermatology Authors: Huaijie Wang, Yitao Duan, Ya Gao, Xinkui Guo Tags: Original Article Source Type: research